Literature DB >> 6254651

Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.

D M Findlay, V P Michelangeli, J A Eisman, R J Frampton, J M Moseley, I MacIntyre, R Whitehead, T J Martin.   

Abstract

Five human breast cancer cell lines (MCF 7, T 47D, BT 20, MDA 157, and MDA 231) and a human breast epithelial cell line (HBL 100) have been found to contain specific high-affinity receptors for 1,25-dihydroxyvitamin D3, Kd values ranged from 0.6 to 2.0 X 10(-11) M and receptor concentration from 31 to 150 fmol/mg cytosol protein. Two of the breast cancer lines (MCF 7 and T 47D) contain specific high-affinity receptors for calcitonin and a calcitonin-responsive adenylate cyclase, which have been characterized with the aid of salmon, eel, and human calcitonins and in several substituted analogues of human calcitonin. The 1,25-dihydroxyvitamin D3 receptor may reflect a normal property of the breast cell. Breast cancer cell lines provide a useful source of 1,25-dihydroxyvitamin D3 receptors. Their coexistence with a calcitonin receptor and biological response in some breast cancers offers the opportunity to investigate new aspects of breast cancer endocrinology.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254651

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 3.  Peptides from the calcitonin genes: molecular genetics, structure and function.

Authors:  L H Breimer; I MacIntyre; M Zaidi
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

4.  A 23-pS Ca2(+)-activated K+ channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cell proliferation.

Authors:  E A Wegman; J A Young; D I Cook
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

5.  The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation.

Authors:  J M Moseley; D M Findlay; J J Gorman; V P Michelangeli; T J Martin
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

6.  Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary.

Authors:  J A Fischer; P H Tobler; M Kaufmann; W Born; H Henke; P E Cooper; S M Sagar; J B Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

Authors:  C M Hansen; T L Frandsen; N Brünner; L Binderup
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

8.  Processing of calcitonin and epidermal growth factor after binding to receptors in human breast cancer cells (T 47D).

Authors:  D M Findlay; K W Ng; M Niall; T J Martin
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

9.  Specific binding of 1,25-dihydroxycholecalciferol in human medullary thyroid carcinoma.

Authors:  H C Freake; I MacIntyre
Journal:  Biochem J       Date:  1982-07-15       Impact factor: 3.857

10.  A pilot study to assess the efficacy of salmon calcitonin in the relief of neuropathic pain caused by extraskeletal metastases.

Authors:  V Kovcin; S Jelić; N Babović; Z Tomasević
Journal:  Support Care Cancer       Date:  1994-01       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.